Sitting Down With... Sauri Gudlavalleti, Global Head of Integrated Product Development Organization (IPDO), Dr. Reddy’s Laboratories.

In what may have been one of the last advanced therapy meetings to go ahead for some time, delegates met in London in late February for CAR-TCR.

The EMA is offering scientists free advice on the development of therapeutics to treat COVID-19.

Sitting Down With... Stephen Tindal, Director, Science & Technology at Catalent Pharma Solutions, to discuss his career in troubleshooting.

The development of a CMV vaccine has been 50 years in the making.

Novosteo has developed a targeted drug combination to help accelerate the repair of bone fractures.

Novel compounds could be effective in treating brain-eating amoeba.

As the industry's reliance on CDMOs increases, how can the sector adapt to meet companies' needs?

How can manufacturing be improved for viral vectors?

Sitting Down With… Mike McMullen, President and CEO, Agilent Technologies, Santa Clara, California, USA.